Hedgehog artificial macrophage with atomic-catalytic centers to combat Drug-resistant bacteria

Yanping Long1, Ling Li2,3, Tao Xu1

  • 1College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, 610065, Chengdu, China.

Nature Communications
|October 23, 2021
PubMed

Insights

Researchers developed a hedgehog artificial macrophage to combat drug-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA). This novel material mimics natural macrophages, offering a promising non-antibiotic strategy for infection control and wound healing.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Infectious Disease Research

Background:

  • Pathogenic drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), pose a significant global health threat.
  • There is an urgent need for novel, non-antibiotic strategies to combat bacterial infections and mitigate the development of antimicrobial resistance.

Purpose of the Study:

  • To design and synthesize a hedgehog artificial macrophage capable of mimicking the "capture and kill" mechanism of natural macrophages.
  • To evaluate the efficacy of this artificial macrophage in combating MRSA and promoting the healing of infected wounds.

Main Methods:

  • Synthesis of a hedgehog artificial macrophage with Fe2N6O atomic-catalytic centers.
  • Experimental studies and theoretical calculations to elucidate the mechanism of action.
  • Assessment of antibacterial activity against MRSA and evaluation of wound healing in a rabbit model.

Main Results:

  • The synthesized artificial macrophage demonstrated efficient capture and killing of MRSA through its unique topography and generation of reactive oxygen species (ROS) like •O2⁻ and HClO.
  • A low minimal inhibition concentration (8 μg/mL) was observed for the Fe-Art M with H2O2.
  • Rapid promotion of bacteria-infected wound healing in rabbit skin was observed.

Conclusions:

  • The hedgehog artificial macrophage presents a viable bionic, non-antibiotic strategy for combating MRSA.
  • Its "capture and kill" capability and high ROS-catalytic activity offer a promising new direction for developing advanced antibacterial materials.